Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This is hormone replacement therapy in the most literal sense
Timeline to Expect: During the first 8 weeks: Many patients notice decreases in appetite and increases in energy levels
Dysregulation of CYP51A1 has been implicated in a spectrum of human diseasesfrom cancer, congenital cataracts, and autoimmune conditions to neurodegenerative and liver diseases
The medication's effects appear equally effective whether administered orally or through subcutaneous injection
The company reported $8.55 in earnings per share (EPS), 156% above last year's results in this area and a full $1.58 above analyst expectations
US$ 26.71
US$ 21.69
US$ 29.39
US$ 21.69
US$ 29.65
